Is Sinopharm the Chinese company that NGIO signed
Post# of 36500
![](/assets/46931549/no_avatar_available_thumb.jpg)
PR - Aug 25 2020
"Letter of Intent (LOI) signed with potential partners in China to develop the Ii-Key-SARS-CoV-2 vaccine for China with a proposed $5 million upfront payment upon contract signing and minimum of $400 million if the vaccine is proven successful in clinical trials."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)